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Background: The adhesion molecule L-selectin is ex-
pressed on the cell surface of lymphocytes and mediates
their migration from the bloodstream into lymph nodes.
L-selectin is able to recognize four glycoprotein ligands,
three of which - Sgp50, Sgp90 and Sgp200 - are sul-
phated, bind specifically to L-selectin and are synthesized
by the high endothelial venules of the peripheral and
mesenteric lymph nodes. One of these three sulphated
L-selectin ligands, Sgp90, has been shown to be identical
to the known surface marker CD34 and is expressed on
the cell surface of endothelial cells. The cDNA encoding
Sgp50 has been cloned, and its product, which has been
designated GlyCAM-1, is secreted. The third ligand,
Sgp200, is both secreted and cell-associated. We have in-
vestigated how the expression of these sulphated glyco-
proteins is regulated during an immune response.
Results: Here we demonstrate that, during a primary
immune response, the expression and secretion of both
GlyCAM-1 and Sgp200 are reduced, recovering to nor-
mal levels 7-10 days after antigen stimulation. In contrast,
the expression of cell-associated CD34 and Sgp200 is rel-
atively unaffected. These results may account for the
modest decreases in the binding of an L-selectin-IgG
fusion protein to high endothelial venules of inflamed
peripheral lymph nodes that have been observed after
antigen exposure. In vivo experiments show that, follow-
ing the decrease in the levels of secreted GlyCAM-1 and
Sgp 200, migration of lymphocytes from the blood stream
into lymph nodes remains L-selectin-dependent, but
more lymphocytes home to antigen-primed than un-
primed peripheral lymph nodes.
Conclusions: We suggest that the secreted forms of the
L-selectin ligands GlyCAM-1 and Sgp200 act as modula-
tors of cell adhesion, and that cell-associated CD34 and
Sgp20 0 are the ligands that mediate the initial loose bind-
ing of lymphocytes to high endothelial venules.
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Background
Lymphocyte migration from the bloodstream into sec-
ondary lymphoid organs, such as the peripheral and
mesenteric lymph nodes and Peyer's patches, is a prereq-
uisite for the generation of an efficient immune response.
This migration is initiated by adhesive interactions
between lymphocyte-homing receptors and their respec-
tive ligands on specialized post-capillary high endothelial
venules (HEVs; [1,2]). The L-selectin homing receptor
is required for the migration of cells to peripheral lymph
nodes [3,4], and it seems that this lectin-like adhesion
molecule is also involved in lymphocyte migration to
mesenteric lymph nodes and, to a lesser extent, to Peyer's
patches [5,6].
Until recently, the ligands present on the HEV surface
that are recognized by L-selectin had been poorly
defined. The production of antibodies to murine HEV
[7,8] and the construction of a chimeric L-selectin-
human immunoglobulin G fusion protein (L-selectin-
IgG; [9]), both of which inhibit lymphocyte binding to
HEV in vitro and leukocyte migration in vivo, have
allowed the molecular identification of three L-selectin
ligands [10-13]. Two of the three ligands were initially
identified by Imai et al. [14] as sulphated glycoproteins of
molecular weights 50 kD and 90 kD that specifically bind
to L-selectin. The cDNA encoding the 50 kD molecule
has been cloned, and its product designated GlyCAM-1
[10]; the 90 kD species was shown to be identical to the
known cell-surface marker molecule CD34 [12].
Another ligand, MAdCAM-1 not only interacts with L-
selectin [15], but also serves as a ligand for integrin
a4p7-bearing lymphocytes that migrate to mesenteric
lymph nodes and Peyer's patches [16], and thus, unlike
GlyCAM-1 and CD34, is not specific for L-selectin. In
all three cases, these endothelial ligands contain highly
O-glycosylated mucin-like domains that seem to serve as
scaffolds for the presentation of carbohydrate ligands to
the lectin domain of L-selectin. Whereas CD34 is a type
I transmembrane protein that is expressed on the luminal
surface of the HEV, GlyCAM-1 is secreted from HEV
cells in vitro and into the bloodstream in vivo, where it is
active as a soluble L-selectin ligand that can block the
adherence of lymphocytes to HEVs [1]. In the same
studies, we showed that there was a third sulphated ligand
that specifically recognizes L-selectin, which was made in
the peripheral and mesenteric lymph nodes. This mol-
ecule had an apparent molecular weight of 180-200 kD
and has been designated Sgp200.
Here we demonstrate that the third of the known sul-
phated L-selectin ligands, Sgp200, is, like GlyCAM-1,
secreted from the peripheral and mesenteric lymph nodes
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and found in normal mouse serum; some Sgp200, how-
ever, is present in a cell-associated form. Furthermore,
although secreted GlyCAM-1 and Sgp200 are down-reg-
ulated 3-4 days after the induction of an immune
response, the levels of CD34 and Sgp200 associated with
peripheral-lymph-node lysates remain largely unaltered
throughout the course of the immune response. De-
creases in the levels of secreted GlyCAM-1 and Sgp200
are only seen in lymph nodes exposed to antigen. Fol-
lowing the decline in the amount of secreted L-selectin
ligands, more lymphocytes migrate to antigen-primed
peripheral lymph nodes, but this migration remains
L-selectin dependent. We suggest that the secreted forms
of the L-selectin ligands Sgp200 and GlyCAM-1 act as
modulators of cell adhesion, and that cell-associated
CD34 and Sgp200 are the ligands that mediate the initial
loose binding of lymphocytes to HEVs.
Results
L-selectin-lgG precipitates at least three sulphated
glycoproteins
It was originally shown that L-selectin-IgG recognized
two sulphated glycoproteins, GlyCAM-1 and CD34,
[141. Subsequent experiments, performed by labeling
peripheral and mesenteric lymph nodes in vivo, demon-
strated that a third sulphated glycoprotein, Sgp2 00 , was
immunoprecipitated by L-selectin-IgG [11]. When
peripheral and mesenteric lymph nodes were labeled in
vitro with [35 S]sodium sulphate and the lysates incubated
with L-selectin-IgG, these same three proteins were
immunoprecipitated (Fig. la, lanes 5 and 8). The precipi-
tation of all three proteins was inhibited by the addition of
10 mM EGTA (Fig. la, lanes 6 and 9) and fucoidan (data
not shown), thus demonstrating that the precipitation
requires the presence of Ca 2+ and is inhibitable by carbo-
hydrates, two features that are diagnostic of L-selectin-lig-
and interactions. Polyclonal antisera recognizing either
GlyCAM-1 or CD34 (Fig. lb, lanes 1-9) were unable to
precipitate Sgp200. Radioimmunoprecipitations also re-
vealed that Sgp200 was present in the supernatants of
peripheral lymph node organ cultures (Figs 2 and 4) and,
at low levels, in the serum of [35S]sodium sulphate-
injected mice, as was another sulphated L-selectin ligand
of molecular weight - 170-180 kD (Fig.1 a, lane 2).
L-selectin-IgG thus recognizes at least three.sulphated
glycoproteins, GlyCAM-1, CD34 and Sgp2 00 . Gly-
CAM-1 and Sgp200 are found in the supernatants and
lysates of lymph node organ cultures as well as in serum,
whereas CD34 is only found in the cultured lymph node
lysate. These results also demonstrate that GlyCAM-1,
CD34 and Sgp2 00 are immunologically distinct.
Effects of an immune response on L-selectin ligands
To study the effects of an immune response on the
expression of L-selectin ligands, animals were first primed
with a topical application of oxazolone (a haptenating
agent that is not antigenic itself but that derivatizes self
Fig. 1. Precipitation analysis of sulphate-labeled lysates from in
vitro-labeled peripheral and mesenteric lymph nodes and in
vivo-labeled mouse serum. Mice were injected with 1 mCi
[35S]sodium sulphate and 4 hours later blood was removed from
them under anaesthesia. Peripheral and mesenteric lymph node
lysates were prepared from in vitro labeled material, as described
in Materials and methods, and blood was allowed to clot
overnight at 4 C. Equal amounts of protein were incubated with
30 i.g of -selectin-lgG, anti-GlyCAM-1 polyclonal antisera or
anti-CD34 polyclonal antisera, and the bound material was pel-
leted with 15 Il protein A-Sepharose beads. The material was
eluted by boiling in SDS and -mercaptoethanol and run on
SDS-polyacrylamide gradient gels. (a) Lanes 1, 4 and 7 show the
total sulphate-labeled material from blood, peripheral and
mesenteric lymph nodes, respectively. Materials precipitated by
L-selectin-lgG are shown in lanes 2, 5 and 8, and the inhibitory
effect of 10 mM EGTA is shown in lanes 3, 6 and 9. (b) Proteins
precipitated with anti-GlyCAM-1 antiserum are shown in lanes 1,
4 and 7, and rabbit polyclonal anti-CD34 immunoprecipitable
material is shown in Lanes 3, 6 and 9. A control immunoprecipi-
tation using a rabbit IgG fraction is shown in lanes 2, 5 and 8.
Samples were subjected to SDS-polyacrylamide gel elec-
trophoresis on either 4-20% gradient gels (a), or 8-20% gels (b).
The data shown are representative of five different experiments;
in each experiment material was pooled from five animals.
proteins, making them antigenic). The oxazolone-modi-
fled proteins are internalized by Langerhans' cells, which
then migrate via the afferent lymphatics to regional
lymph nodes where an immune response is initiated. The
results of representative immunoprecipitations of [35S]-
labeled material from organ culture supernatants and
lysates are shown in Figures 2a-c, and are graphically
depicted in Figures 2d and 2e. The first effect of the
immune response on the draining peripheral lymph
node, seen on day 3, was a 3-4 fold reduction in total sul-
phate incorporation per unit protein concentration (Fig.
2e). Levels returned to normal 7 days after oxazolone
exposure. The levels of newly sulphated Gly-CAM-1
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Fig. 2. Analysis of sulphate-labeled supernatants and lysates from
peripheral lymph nodes with increasing time after priming with
oxazolone. Peripheral lymph nodes were removed from normal
or oxazolone-primed mice and labeled with [35Slsodium sul-
phate, and supernatants and lysates were prepared as described
in Materials and methods. The amount of protein was assessed
and, as the immunized nodes incorporated less sulphate
(8723 + 465 c.p.m. per 500 [Ig tissue, day 4 post-priming) than
naive controls (14458 _ 1032 c.p.m. per 500 Rg tissue, day 4
post-priming), equal amounts of protein were incubated with
30 [Lg of L-selectin-lgG, 15 pLg anti-GlyCAM-1 or 20 Ipg anti-
CD34 antisera and the bound material was pelleted with 15 Il
protein A-Sepharose beads. The bound material was eluted and
run on 4-20 % SDS-polyacrylamide gradient gels. (a,b) The
results of representative radioimmunoprecipitations from super-
natants using L-selectin-lgG or anti-GlyCAM-1, respectively. (c)
Radioimmunoprecipitations from lysates using L-selectin-lgG.
(d) A graphical representation of the quantitated material from
supernatants. (e) Quantification of materials from lysates. Gels
were analyzed on a Fujix scanner and the amount of radioactiv-
ity in the total cell lysate (total sulphate), the 50 kD (GlyCAM-1),
90 kD (CD34) and 200 kD (Sgp200) bands quantified. The data
are expressed as the percentage of the normal unprimed periph-
eral lymph nodes. The results shown are representative of ten
similar experiments, in which no less than four mice were sacri-
ficed at each time point.
associated with both the organ culture supernatants and
lysates dropped by - 85-95 % 3-4 days after exposure to
arntigen (Fig. 2) and were returning to normal levels 7
days after priming. Levels of Sgp200 in the supernatants
dropped following immune challenge (Figs 2a and 2d),
but the levels of Sgp200 and CD34 in the lysates
remained steady following antigenic stimulation (Figs 2c
and 2e). Northern blot analysis revealed that 3-5 days
after antigenic stimulation there was a 90-95 % reduction
in the level of GlyCAM-1 messenger (m)RNA (Fig. 3a).
In contrast, the level of CD34 mRNA remained robust
during this period (data not shown). These data clearly
demonstrate that following antigenic stimulation there is
a dramatic reduction in the levels of GlyCAM-1.
The decrease in GlyCAM-1 and Sgp200 synthesis is localized
to the antigen-primed lymph node and is independent of the
type of antigenic stimulus
The application of contact sensitisers such as oxazalone
can, on occasion, result in a generalized priming of all
peripheral lymph nodes due to animal grooming habits.
Thus, to determine whether the decrease in secreted
GlyCAM-1 and Sgp200 was specifically related to anti-
genic stimulation, animals were immunized subcuta-
neously with sheep red blood cells (SRBC) in Ribi
adjuvant. This treatment results in the local priming, as
determined by increased size, of only the popliteal
lymph node and, occasionally, the inguinal lymph node
on one side of the animal - that is, the draining lymph
nodes. The same lymph nodes from the other side of the
animal - the contralateral lymph nodes - that are not
primed can be used as an internal control. Four days later
the draining and contralateral lymph nodes were
removed separately from the same SRBC-primed animal
and labeled in vitro with 135 S]sodium sulphate. As a fur-
ther control, the same peripheral lymph nodes were also
removed from naive animals and sulphate-labeled. Only
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mRNA, as compared to the contralateral (unprimed)
peripheral lymph node (Fig. 3b) or to peripheral lymph
nodes from naive animals (data not shown). This
decrease was independent of the nature of the antigen as
similar results were obtained from animals that were
primed with SRBC, oxazolone or KLH in adjuvant
(data not shown).
Fig. 3. Northern analysis of GlyCAM-1 mRNA levels. (a) RNA
isolated from the peripheral lymph nodes of naive and oxa-
zolone-treated mice at the times shown, and the GlyCAM-1
mRNA levels were analyzed as described in Materials and meth-
ods. As a loading control, the same blot was probed with the
mouse actin cDNA; the low levels of actin message in the day 0
and day 1 samples are due to the fact that less RNA was loaded
at these time points. (b) RNA isolated from either the popliteal
lymph nodes that were primed with oxazolone or SRBC 4 days
earlier (+), or the unprimed contralateral nodes (-).
nodes exposed to antigen showed a 2-3 fold decrease in
the level of sulphate incorporation and dramatic
decreases (- 5 % normal levels) in the levels of Gly-
CAM-1 and Sgp200 in the supernatant (Fig. 4). Once
again, northern analysis of GlyCAM-1 mRNA levels
revealed that 4 days following antigenic stimulation there
was a 90-95 % reduction in the level of GlyCAM-1
Expression of L-selectin ligands following antigenic
stimulation
Although the preceding data demonstrate that GlyCAM-1
secretion is down-regulated during an immune response,
it remained a possibility that GlyCAM-1 (despite the fact
that it is not a membrane-bound protein) somehow re-
mains loosely associated with the HEV in the surround-
ing glycocalyx. To examine this possibility, we carried out
an immunohistochemical analysis, using polyclonal Gly-
CAM-1 and CD34 antisera (Fig. 5) and L-selectin-IgG
(Fig. 6), of lymph nodes from animals primed with oxa-
zolone. The first point to note is that CD34 staining
remained robust at all time points (Fig. 5). GlyCAM-1
staining, on the other hand, was intense in unprimed
animals (day 0) but exhibited a dramatic decrease 1 day
after priming with oxazolone. Staining was minimal 3
days after exposure to oxazolone but was increasing in
intensity by day 7 and was normal after 10 days.
L-selectin-IgG staining was intense at day 0, reduced in
intensity at days 3 and 7 after antigen priming and
attained normal levels by day 10.
The decrease in GlyCAM-1 synthesis scen in cultured
peripheral lymph nodes was thus reflected in a decrease
in immunohistochemical staining of the peripheral
lymph node HEV. In addition, immunohistochemical
analysis showed that L-selectin-IgG is still capable of
binding to the HEV of primed peripheral lymph nodes
(Fig. 6); the staining is, however, reduced in intensity at
days 3 and 7. These data suggest that, although the Gly-
CAM-1 ligand accounts for a large percentage of the
staining seen in resting peripheral lymph nodes, in
Fig. 4. The decrease in GlyCAM-1 and
Sgp200 synthesis is localized to drain-
ing lymph nodes. Peripheral lymph
nodes were removed from either naive
animals or animals primed locally with
SRBC in Ribi adjuvant 4 days earlier;
the lymph nodes were labeled with
[35S]sodium sulphate in vitro and super-
natants collected. In the case of the anti-
gen-primed mice, both the peripheral
lymph nodes draining the antigen prim-
ing site and the contralateral (unprimed)
peripheral lymph nodes were taken. (a)
The L-selectin-lgG precipitable material
in supernatants from naive lymph nodes
(lane 1), contralateral lymph nodes (lane
4) and lymph nodes draining the site of
antigen priming (lane 7). The inhibitory
effect of 10 mM EGTA on those precipitations is shown in lanes 2, 5 and 8, respectively. Material precipitable by anti-GlyCAM-1 anti-
serum is shown in Lanes 3, 6 and 9. (b) The data in (a) after quantification of the bands on the Fujix scanner, expressed as percentage
of that observed in naive (unprimed) control peripheral lymph nodes. The data shown are representative of four similar experiments in
which each group contained five mice.
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Fig. 5. Immunohistochemical staining of peripheral lymph nodes with anti-GlyCAM-1 and anti-CD34 antisera. Staining was performed
on peripheral lymph nodes 0, 3, 7 and 10 days after antigen priming, as described in Materials and methods. The main part of each
image shows the peripheral lymph nodes at 10 x magnification and the insets show an HEV at 40 x magnification. The data are repre-
sentative of three similar experiments in which each group contained six mice.
primed lymph nodes the major L-selectin ligands are
CD34 and Sgp200.
Migration of naive cells into an inflamed peripheral lymph
nodes is L-selectin dependent
The experiments described above raised the question of
whether the migration of cells to antigen-primed lymph
nodes became L-selectin independent. To address this
issue, a migration experiment was performed using naive
peripheral-lymph-node cells. The cells were labeled with
[5 lCr]sodium chromate, mixed with either MEL-14 (an
anti-L-selectin blocking monoclonal antibody; [17,18]),
or isotype-matched normal rat IgG 2a, and injected into
syngeneic recipients that were either unprimed (day 0),
or primed with oxazolone 4 hours or 1, 2, 3, 4, 7, 10 or
14 days earlier. After 2 hours the animals were sacrificed
and the tissues described in the Materials and methods
were collected. Although only the data for the peripheral
lymph node are shown, other tissues were collected in
order to ensure that either treatment of the cells with
antibody or the induction of an immune response does
not perturb the overall migration patterns; such perturba-
tions were not seen. The peripheral lymph nodes were
weighed prior to counting and the radioactivity expressed
as c.p.m. per node. The results of these experiments (Fig.
7) clearly show that migration of naive lymphocytes to
peripheral lymph nodes is L-selectin dependent, regard-
less of whether the peripheral lymph nodes are naive or
antigen-primed. If the counts are expressed as c.p.m. per
node, then it can be seen that more lymphocytes
migrated to the antigen-primed peripheral lymph node;
this increase parallels the increase in size of the peripheral
lymph node following antigenic stimulation.
Discussion
These studies confirm the existence of a third L-selectin-
specific ligand, Sgp200, and suggest that this molecule is
associated with the peripheral lymph node as well as
Fig. 6. Immunohistochemical staining
with L-selectin-lgG of an HEV in a
naive peripheral lymph node (day 0) or
peripheral lymph nodes at 3, 7 and
10 days after priming with oxazolone.
Cryostat sections (6-8 im in thickness)
from control or immunized lymph
nodes were stained with gold-conju-
gated L-selectin-lgG (5 pIg per section);
bound L-selectin-lgG was detected by
silver enhancement. These data are rep-
resentative of two experiments in which
each group contained six mice.
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Fig. 7. Lymphocyte migration after anti-
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mice, labeled with [5 1Cr]sodium chro- 700
mate and mixed with MEL-14 or rat IgG. - 600 -
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1 x 106 cells and 100 Ipg antibody intra- + 500
venously in a volume of 200 RI. The
recipients were either naive (day 0) or v 400-
had been primed systemically with oxa- 300
zolone 4 hours or 1, 2, 3, 4, 7, 10 or 14 :
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recipients were bled tor a Il bloo d - 100 -
sample, sacrificed, and the peripheral 100
and mesenteric lymph nodes, Peyer's 0 -. ,. 0
patches, liver, lungs and spleen were 0 5 10 15
removed and the level of radioactivity Days after antigen priming
determined in a gamma counter. The
number of counts present in the various
organs is expressed as c.p.m. per peripheral lymph node in the presence or absence of MEL-14. These data are representative of three
similar experiments in which each group contained at least five animals. The error bars represent 1 standard deviation.
being secreted. Sgp200 is also present in normal mouse
serum and is immunologically distinct from GlyCAM-1
and CD34. On induction of a primary immune response,
the levels of GlyCAM-1 and Sgp200 in the supernatants
of the peripheral lymph node organ cultures fall to
almost undetectable levels, while the levels of Sgp200 in
cell lysates remain essentially normal. At the same time,
the levels of sulphated CD34 and its cell-surface expres-
sion remain virtually unchanged. These results suggest
that Sgp200 may exist as both a secreted and a cell-asso-
ciated molecule. Another possibility is that there are two
molecules of similar molecular mass, one of which, like
GlyCAM-1, is secreted and the other of which, like
CD34, is cell-associated. The migration of lymphocytes
to lymph nodes that have down-regulated their secretion
of GlyCAM-1 and Sgp200 is still dependent on
L-selectin. Rosen and colleagues [19] have also studied
Sgp200 and have shown that it is MECA-79-reactive and
requires sulphate for its interaction with L-selectin.
MECA-79 is a monoclonal antibody that recognizes
peripheral lymph node HEV [7] and, more specifically,
sulphated carbohydrates that are critical for the inter-
action of L-selectin with its ligands [19].
Our finding that there are at least two L-selectin ligands,
GlyCAM-1 and Sgp200, that can be secreted raises the
issue of the physiological significance of the soluble
L-selectin ligands. One possibility is that they competi-
tively inhibit cell migration to resting peripheral lymph
nodes. This is an attractive theory in the light of the
observations that only 25 % of lymphocytes that enter an
unstimulated lymph node from the blood undergo
extravasation, and that adhesion to HEVs is selective for
T and B cells with the exclusion of other leukocytes
[20,21]. Following the induction of an immune response,
an increased number of lymphocytes migrate to the
primed lymph node in an L-selectin-dependent manner;
elevated levels of other cell types, such as monocytes and
neutrophils, which can bind to the HEV, are also found
in the primed lymph node. Therefore, another possibility
is that soluble L-selectin ligands act to modulate the
adhesion of various subsets of cells to the peripheral
lymph node during an immune response.
Although L-selectin was originally described as an adhe-
sion molecule involved only in the migration of lympho-
cytes to peripheral lymph nodes [10], subsequent studies
have shown that this molecule is expressed on all leuko-
cytes, except memory T cells [22]. L-selectin also seems
to be crucial for mediating the influx of other white
blood cells, such as neutrophils and monocytes, into
acute inflammatory sites. For example, Marchesi and
Gowans [23] demonstrated that neutrophils are able to
bind to HEVs, and it was later demonstrated that circu-
lating neutrophils bind HEVs more readily following
antigenic challenge of the lymph node [22]. In addition,
it has been shown that monocytes bind poorly, if at all, to
the HEV of unstimulated peripheral lymph nodes but
bind actively and in an L-selectin-dependent manner to
the HEV of peripheral lymph nodes taken from animals
3 days after antigen priming [24].
The suggestion that, during an immune response, there is
an increase in the number of neutrophils and monocytes
in a lymph node is not new [25,26], and our own fluores-
cence-activated cell sorting (FACS) analysis of peripheral
lymph nodes from mice that had been primed with oxa-
zolone 3-5 days earlier confirm these observations. We
found that, in comparison to unprimed controls, the
number of T and B cells in the primed peripheral lymph
node increased - 1.5 fold and 4-5 fold, respectively, and
that the number of monocytes/macrophages increased by
7-9 fold (N. Ehsani and S.R.W, unpublished observa-
tions). Thus, in addition to the possibility that GlyCAM-
1 and/or Sgp2 00 may play a role as competitive regulators
of lymphocyte migration, these molecules may also be in-
volved in modulating the entry of neutrophils and mono-
cytes into peripheral lymph nodes or acute inflammatory
sites. Whether these molecules both perform the same
function, or whether one acts upon monocytes and neu-
trophils and the other competes with lymphocytes for L-
selectin ligands on HEVs, is a matter open to conjecture.
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Another interpretation of the data is that the soluble
selectin ligands may be involved in cell signaling. The
results presented here indicate that CD34 or Sgp200 are
sufficient to mediate adhesion of lymphocytes, via L-
selectin, to the peripheral lymph node HEV at a time
when the levels of soluble GlyCAM-1 and Sgp200 are
decreased. We speculate that the decrease in soluble L-
selectin ligands, either locally or systemically, results in
the increased occupancy of L-selectin on the HEV sur-
face by other ligands, such as CD34 or Sgp 200, at the
time of antigen challenge. This higher L-selectin occu-
pancy by the HEV-associated ligands might induce a pre-
activation signal in naive lymphocytes that enables them
to cope more efficiently with the antigenic insult. Fur-
thermore, because it has been shown that CD34 can be
phosphorylated after stimulation with phorbol esters in
some cell types [27], and that anti-CD34 antibodies may
induce cellular aggregation [28], it is possible that the
engagement of a increased number of CD34 or Sgp200
molecules on the endothelial cell surface by lymphocyte
L-selectin could lead to a change in adhesive properties
of the HEV.
It is worth noting that the use of the total protein content
in lymph nodes as the baseline against which GlyCAM-1
expression is measured may introduce a distortion into
the quantification of our data. As is apparent in Figures 5
and 7, lymph nodes that drain the sites of antigen injec-
tion or skin-painting with haptens increase substantially
in size. Therefore, it is possible that, if the HEV cell con-
tent does not increase in size in parallel with the lymph
node, the expression of GlyCAM-1 may be underesti-
mated. Previous studies have shown that there is also an
increase in the surface area of the HEV during antigenic
stimulation [29], however, this increase lags behind the
increase in size observed in the T cell-dependent areas of
the lymph node, thus making quantification of the rela-
tive increases difficult. It may be possible in the future to
use another marker that, while specific for HEV, is not
altered by the induction of an immune response and
would therefore allow a more accurate standardization of
the data. Nevertheless, these results, together with the
immunohistochemistry data, do indicate that GlyCAM-1
is down-regulated during an immune response; the
down-regulation is maximal 3-4 days after antigenic
stimulation and GlyCAM-1 levels return to normal
7-10 days after antigenic challenge.
Conclusions
These studies demonstrate that there are three L-selectin
ligands present in naive lymph nodes. Two of these lig-
ands, Sgp200 and GlyCAM-1, are secreted from resting
lymph nodes and are down-regulated during an immune
response; Sgp200 is also associated with the HEV cell sur-
face. It is not clear whether the cell surface and secreted
forms of Sgp200 are the same - molecular characteriza-
tion will be necessary in order to determine their rela-
tionship to one another. If the secreted and cell-associated
forms of Sgp200 are different, alternative RNA splicing
may be responsible; if this is the case then it will be inter-
esting to determine whether the splicing event itself is
regulated by an immune response. Finally, it is possible
that lymphocyte migration should not be thought of as
the simple interaction of a receptor on the surface of
lymphocytes with its cognate ligand on the HEV surface.
In a resting peripheral lymph node there may be com-
petition for these interactions; following the induction of
an immune response this competition may be reduced,
thus allowing a more diverse cell population to enter the
lymph node.
Materials and methods
Animals and antigen priming
Six to eight week old BALB/c female mice were used
throughout these studies. They were primed with either a 1 %
solution of oxazolone (Sigma), which was painted on the ani-
mal in the groin and shoulder areas to induce a response in the
brachial, axillary, inguinal, cervical and popliteal lymph nodes,
or 2 % sheep red blood cells (SRBC) in Ribi adjuvant or
200 [pg keyhole limpet haemocyanin (KLH) in Ribi adjuvant.
The latter reagents were administered subcutaneously in a vol-
ume of 25 pxl and induced responses only in the draining
popliteal lymph nodes and occasionally the inguinal lymph
nodes on the same side of the animal.
Chimeric proteins
The L-selectin-IgG chimera and its production, purification
and biological properties have been extensively described [9].
The CD4-IgG control chimera, has been described by Capon
et al. [30].
Immunohistochemical staining of HEV with L-selectin-lgG
The L-selectin-IgG chimera was conjugated to 10 nm gold
particles (electron microscopic grade; Zymed) and used to stain
6-8 pLm thick cryostat sections of murine peripheral lymph
nodes that had been fixed in ice-cold acetone. Sections were
preincubated with Dulbecco's phosphate-buffered saline (D-
PBS)/0. 1 % BSA containing 200 ,pg m1-1 CD4-IgG. After the
removal of this material the gold-conjugated chimera was
added at a concentration of 50 Izg ml-1 in D-PBS containing
200 pLg ml-1 CD4-lgG. The staining was performed at 4 °C
with rotation at 65 r.p.m. for 40 minutes. After this time the
gold conjugate was gently decanted and the sections slowly
immersed in 2.5 % glutaraldehyde in D-PBS. The staining was
silver-enhanced using the Enhance kit (Amersham) prior to
counterstaining of the sections with aqueous haematoxylin
(Biomeda). Sections were mounted in cystal mount (Bio-
meda) for microscopic observation.
Immunohistochemical staining of sections with anti-
GlyCAM- I and anti-CD34 polyclonal antisera
Immunohistochemistry was performed as previously described
on either fresh-frozen or periodate-lysine-paraformaldehyde
(PLP) fixed tissue sections [31]. Briefly, 5-8 (pm paraffin sec-
tions were deparaffinized in xylene for 10 minutes, rinsed in
water, and endogenous peroxidase activity was quenched with
1 % H,2 0 2 for 30 minutes. For staining with the anti-CD34
antibody, sections were immersed in 0.1 M citrate buffer
(pH 6.0) and microwaved twice on high power for 3 minutes
followed by 20 minutes at room temperature. For staining
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with the anti-GlyCAM-1 antibody the citrate antigen-retrieval
step was replaced by a 3 minute pepsin digestion at 37 °C.
Nonspecific binding was blocked by a 30 minute preincuba-
tion with 10 % normal mouse serum and followed by a
30 minute room- temperature incubation with the appropriate
dilution of antibody. Sections were rinsed in PBS, incubated
with biotinylated goat-anti-rabbit IgG (Vector Laboratories)
for 30 minutes, rinsed again and incubated with the Vector
Elite ABC reagents (streptavidin-horseradish peroxidase conju-
gate) as specified by the manufacturer's instructions. Substrate
(diaminobenzidine (DAB), Dako) was added for 5 minutes and
staining was enhanced by a 10 second incubation with a DAB-
enhancing solution (Vector Laboratories), used according to
the manufacturer's instructions. Sections were counterstained
with Mayer's haematoxylin, dehydrated, and mounted in
synthetic mounting medium.
In vitro organ culture
Peripheral lymph nodes were aseptically removed from anti-
gen-primed or unstimulated mice, the excess fatty tissue was
detatched and the lymph nodes were sliced into 1-2 mm
pieces. The slices were cultured in 1 ml D-PBS (containing
10 Vpg ml- t glucose and antibiotics) in the presence of 250 luCi
[35S]sodium sulphate (ICN Radiochemicals); the organ culture
was carried out at 37 °C in humidified air containing 5 %
CO 2. After 3 hours the supernatants were removed from the
cultures. The tissue slices were washed three times with
D-PBS, after which lysis buffer (1 ml D-PBS containing 2 %
Triton X100, 0.1 % sodium azide and 10 units aprotinin) was
added and the tissue disintegrated with the aid of a Tissuemizer
(Baxter). Lysis was continued for a further 30 minutes at 4 °C
and was followed by centrifugation of the lysates and super-
natants at 5 000 x g. The resulting materials were precleared
overnight at 4 C by the addition of protein A-Sepharose
(Pharmacia) as described by Imai et al. [14]. Prior to using the
sulphate-labeled material the protein concentrations were
determined using the BCA protein assay reagent (Pierce). Sul-
phate incorporation was calculated by determining the ace-
tone-precipitable radioactivity obtained from 100 ul of labeled
lysate. For all immunoprecipitations described in these studies
equal amounts of protein were used.
In vivo-labeling experiments
Mice were injected intravenously with 1 mCi [35 S]sodium sul-
phate; 4 hours later the animals were exsanguinated and the
peripheral and mesenteric lymph nodes and Peyer's patches
were removed. The blood was allowed to clot at room tem-
perature and was placed at 4 °C overnight to allow retraction
of the clot and the removal of serum. The organs were lysed as
described above and the immunoprecipitations with
L-selectin-IgG, anti-GlyCAM-1 and anti-CD34 antibodies
performed as described below. All immunoprecipitations were
carried out using equal amounts of protein.
Radioimmunoprecipitations of L-selectin ligands
Radioimmunoprecipitations using purified L-selectin-IgG
(30 ig ml- t) were performed as described by Imai et al. [14].
Radioimmunoprecipitations using polyclonal antisera against
GlyCAM-1 and CD34 were performed as described in Lasky
et al. [10] and Baumhueter et al. [12,31], respectively.
Northern blot analysis
Agarose-formaldehyde gel electrophoresis in MOPS buffer of
RNA samples was carried out as described [3]. RNA was
directly transferred using a Posiblot apparatus (Stratagene, La
Jolla, California) for 45 minutes onto Bioblot NC nitrocellulose
(Costar, Cambridge, Massachusetts). GlyCAM-1 and actin
RNAs were visualized by hybridization with the appropriate
[32 p] radiolabeled probe generated by random priming as
described [32].
Lymphocyte migration in vivo
Peripheral lymph nodes were removed from naive BALB/c
mice and single-cell suspensions were prepared and labeled
with [51Cr] sodium chromate as previously described [33]. The
labeled cells were washed and mixed with either MEL-14 or
rat IgG2 (100 sIg per 106 cells) and 4 x 106 cells injected into
syngeneic recipients that were either naive or had been system-
ically primed with oxazolone 4 hrs or , 2, 3, 4, 7, 10 or 14
days earlier. Two hours after injection the recipients were bled
for a 50 l blood sample, cervically dislocated and the periph-
eral and mesenteric lymph nodes, Payer's patches, spleen, liver,
lungs, and thymus were removed for quantitation\ of radioac-
tivity in a gamma counter. The antigen-primed and naive
lymph nodes were weighed and the number of counts present
in these tissues expressed as c.p.m. per peripheral lymph node.
Each animal received between 150 000 and 165 000 total
c.p.m. and 2 hours later only 134-155 c.p.m. remained in a
50 l1 sample of blood in all groups.
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